Viewing Study NCT01808092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT01808092
Status: COMPLETED
Last Update Posted: 2017-09-06
First Post: 2013-02-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nosocomial Pneumonia (NP) View
None Ventilator-associated Pneumonia (VAP) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ceftazidime, View
None Meropenem, View
None Anti-Bacterial Agents, View
None Anti-Infective Agents, View
None Therapeutic Uses, View
None Pharmacologic Actions, View
None Physiological Effects of Drugs View